Log in

NASDAQ:ICUIICU Medical Stock Price, Forecast & News

$186.63
-2.22 (-1.18 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$184.21
Now: $186.63
$188.08
50-Day Range
$172.31
MA: $185.00
$194.00
52-Week Range
$148.89
Now: $186.63
$236.51
Volume98,488 shs
Average Volume162,023 shs
Market Capitalization$3.91 billion
P/E Ratio46.20
Dividend YieldN/A
Beta0.52
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation/urologics, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Read More
ICU Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.25 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 billion
Cash Flow$12.40 per share
Book Value$66.62 per share

Profitability

Net Income$101.04 million

Miscellaneous

Employees8,000
Market Cap$3.91 billion
Next Earnings Date11/9/2020 (Estimated)
OptionableOptionable
$186.63
-2.22 (-1.18 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

How has ICU Medical's stock price been impacted by COVID-19 (Coronavirus)?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ICUI stock has increased by 3.4% and is now trading at $186.63.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of ICU Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for ICU Medical
.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) issued its quarterly earnings results on Monday, August, 10th. The medical instruments supplier reported $1.65 EPS for the quarter, beating the consensus estimate of $1.24 by $0.41. The medical instruments supplier earned $303.40 million during the quarter, compared to analysts' expectations of $283.37 million. ICU Medical had a net margin of 6.87% and a return on equity of 10.45%. The firm's revenue for the quarter was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.99 EPS.
View ICU Medical's earnings history
.

What price target have analysts set for ICUI?

3 brokerages have issued 12-month target prices for ICU Medical's shares. Their forecasts range from $199.00 to $210.00. On average, they anticipate ICU Medical's stock price to reach $204.50 in the next year. This suggests a possible upside of 9.6% from the stock's current price.
View analysts' price targets for ICU Medical
.

Has ICU Medical been receiving favorable news coverage?

Headlines about ICUI stock have been trending neutral recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. ICU Medical earned a news sentiment score of 0.0 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about ICU Medical
.

Are investors shorting ICU Medical?

ICU Medical saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 263,700 shares, a decrease of 17.1% from the May 31st total of 318,100 shares. Based on an average daily volume of 187,500 shares, the short-interest ratio is currently 1.4 days. Approximately 1.4% of the company's shares are short sold.
View ICU Medical's Short Interest
.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), BlackRock (BLK), Alibaba Group (BABA), CA (CA), NVIDIA (NVDA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), ServiceNow (NOW) and Chipotle Mexican Grill (CMG).

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, Chairman & CEO (Age 47)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 56)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61)

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.78%), Nuance Investments LLC (3.37%), Victory Capital Management Inc. (1.93%), Silvercrest Asset Management Group LLC (1.76%), GW&K Investment Management LLC (1.24%) and Bank of New York Mellon Corp (0.96%). Company insiders that own ICU Medical stock include Christian B Voigtlander, Elisha W Finney, George A Lopez, Kevin J Mcgrody, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends for ICU Medical
.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including GW&K Investment Management LLC, Federated Hermes Inc., Victory Capital Management Inc., Chartwell Investment Partners LLC, Glenmede Trust Co. NA, New York State Common Retirement Fund, Vanguard Group Inc., and State of Tennessee Treasury Department. Company insiders that have sold ICU Medical company stock in the last year include Elisha W Finney, George A Lopez, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone, and Vivek Jain.
View insider buying and selling activity for ICU Medical
.

Which major investors are buying ICU Medical stock?

ICUI stock was bought by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Boston Trust Walden Corp, Assenagon Asset Management S.A., Russell Investments Group Ltd., Canada Pension Plan Investment Board, Mackay Shields LLC, Marshall Wace LLP, and WINTON GROUP Ltd.
View insider buying and selling activity for ICU Medical
.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $186.63.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $3.91 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $101.04 million in net income (profit) each year or $7.36 on an earnings per share basis. ICU Medical employs 8,000 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.